{'52WeekChange': 1.8363228,
 'SandP52WeekChange': 0.0644362,
 'address1': '545 Fifth Avenue',
 'address2': 'Suite 1400',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 25.5,
 'askSize': 800,
 'averageDailyVolume10Day': 272125,
 'averageVolume': 243722,
 'averageVolume10days': 272125,
 'beta': None,
 'beta3Year': None,
 'bid': 25,
 'bidSize': 800,
 'bookValue': 7.093,
 'category': None,
 'circulatingSupply': None,
 'city': 'New York',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 27.14,
 'dayLow': 25.18,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': 403488480,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 35.82943,
 'fiftyTwoWeekHigh': 57.39,
 'fiftyTwoWeekLow': 8.5,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 11462061,
 'forwardEps': -4.12,
 'forwardPE': -6.1407766,
 'fromCurrency': None,
 'fullTimeEmployees': 13,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.23326999,
 'heldPercentInstitutions': 0.39845002,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/appliedtherapeutics.com',
 'longBusinessSummary': 'Applied Therapeutics, Inc., a biopharmaceutical '
                        'company, develops novel products to target '
                        'cardiovascular disease, galactosemia, and diabetic '
                        'complications. Its lead product candidate is AT-007 '
                        'that is in phase I/II for the treatment of '
                        'galactosemia; AT-001 that is in phase II clinical '
                        'trials for treating diabetic cardiomyopathy, as well '
                        'as is in phase I clinical trials to treat diabetic '
                        'peripheral neuropathy; and AT-003 that is in phase I '
                        'clinical trial for the treatment diabetic '
                        "retinopathy. The company's preclinical stage products "
                        'include AT-104 for the treatment of orphan '
                        'hematological oncology. Applied Therapeutics, Inc. '
                        'was founded in 2016 and is headquartered in New York, '
                        'New York.',
 'longName': 'Applied Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 559808000,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_559189115',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -49152000,
 'nextFiscalYearEnd': 1640908800,
 'open': 27.14,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '212 220 9226',
 'previousClose': 27.05,
 'priceHint': 2,
 'priceToBook': 3.566897,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 27.14,
 'regularMarketDayLow': 25.18,
 'regularMarketOpen': 27.14,
 'regularMarketPreviousClose': 27.05,
 'regularMarketPrice': 27.14,
 'regularMarketVolume': 129568,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 22126800,
 'sharesPercentSharesOut': 0.0542,
 'sharesShort': 1198503,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 718361,
 'shortName': 'Applied Therapeutics, Inc.',
 'shortPercentOfFloat': 0.0896,
 'shortRatio': 4.99,
 'startDate': None,
 'state': 'NY',
 'strikePrice': None,
 'symbol': 'APLT',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.95,
 'twoHundredDayAverage': 40.002735,
 'volume': 129568,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.appliedtherapeutics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '10017'}